Related Experiment Video
Updated: Jul 31, 2026
08:16
Detection of Live Escherichia coli O157:H7 Cells by PMA-qPCR
Published on: February 1, 2014
17.3K
Use of data mining at the Food and Drug Administration
Hesha J Duggirala1, Joseph M Tonning2, Ella Smith3
1Center for Veterinary Medicine, FDA Hesha.Duggirala@fda.hhs.gov.
Summary
This article reviews data mining at the United States Food and Drug Administration (FDA), covering current and past activities. It discusses the advantages, challenges, and future of data mining for product safety and regulatory oversight.
Area of Science:
- Regulatory Science
- Data Science
- Public Health
Background:
- The United States Food and Drug Administration (FDA) regulates a wide array of products, including medical products, food, veterinary products, nutrition, and tobacco.
- Ensuring the safety and efficacy of these regulated products is a critical public health mandate.
- Data mining offers powerful tools to analyze vast datasets for improved regulatory decision-making.
Purpose of the Study:
- To provide a comprehensive overview of data mining initiatives at the FDA.
- To inform data miners, stakeholders, and the public about the FDA's data mining landscape.
- To highlight the scope and impact of data mining on FDA's regulatory functions.
Main Methods:
- Summarizing historical and ongoing data mining projects within the FDA.
- Describing the types of data utilized in FDA data mining activities.
- Analyzing the benefits and limitations associated with implementing data mining at the FDA.
Main Results:
- Routine and developmental data mining activities are integral to FDA operations.
- Various FDA datasets are subjected to data mining for safety and compliance monitoring.
- Data mining presents both significant opportunities and challenges for the FDA's mission.
Conclusions:
- Data mining is a crucial and evolving component of the FDA's regulatory framework.
- Future directions emphasize expanding data mining capabilities for enhanced product safety oversight.
- Continued investment in data mining is essential for the FDA to meet future public health challenges.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).